Basic and Diluted Earnings (Loss) per Share (Tables)

6 Months Ended

Jun. 30, 2022

Earnings Per Share [Abstract]

Basic and Diluted Earnings (Loss) per Share

The following table presents information necessary to calculate earnings (loss) per share:

	Three Months Ended June 30,						Six Months Ended June 30,
	2022			2021			2022			2021
Numerator:
Net income (loss) attributable to Thorne HealthTech, Inc.	$	(5,590,705	)	$	(88,230	)	$	(611,646	)	$	4,618,260
Undistributed earnings (loss) attributable to Series E convertible preferred stockholders		—			(88,230	)		—			4,618,260
Numerator for basic earnings (loss) per share—net income (loss) available to Thorne HealthTech, Inc. common stockholders (A)		(5,590,705	)		—			(611,646	)		—
Effect of dilutive securities:
Undistributed earnings (loss) attributable to Series E convertible preferred stockholders—basic		—			(88,230	)		—			4,618,260
Undistributed earnings (loss) attributable to Series E convertible preferred stockholders—diluted		—			88,230			—			(4,618,260	)
Numerator for diluted earnings (loss) per share—net income (loss) available to Thorne HealthTech, Inc. common stockholders (C)		(5,590,705	)		—			(611,646	)		—
Denominator (1):
Denominator for basic earnings (loss) per share—weighted average shares (B)		52,731,604			17,650,035			52,648,653			17,650,035
Denominator for diluted earnings (loss) per share—adjusted weighted average common stock and common stock equivalents (D)		52,731,604			17,650,035			52,648,653			17,650,035
Basic earnings (loss) per share (A/B)	$	(0.11	)	$	—		$	(0.01	)	$	—
Diluted earnings (loss) per share (C/D)	$	(0.11	)	$	—		$	(0.01	)	$	—

(1) For the three and six months ended June 30, 2022, 18.1 million and 17.2 million warrants and stock-based awards, respectively, were excluded from the computation of diluted earnings (loss) per share because the effect would have been anti-dilutive under the treasury stock method.